When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.
An RNA interference therapy, targeting ANGPTL3 in the liver, drastically reduced fasting triglycerides in people with mixed hyperlipidemia, the ARCHES-2 trial showed. Used atop usual statins and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback